JENNIFER WILEY: Open Payments
NPI 1821660978 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 24 payments from 17 companies in 2025. Trend: 2023 $429 · 2024 $385 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Corcept Therapeutics | 2 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Alkermes, Inc. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
Products named: GVOKE HYPOPEN, Korlym, JOURNAVX, Kerendia, MOUNJARO, VIVITROL, FANAPT, REXULTI.
Industry payments across GA — which companies pay providers there.
